Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Improved Anticancer Delivery of Paclitaxel by Albumin Surface Modification of Plga Nanoparticles Publisher Pubmed



Esfandyarimanesh M1, 2 ; Mostafavi SH2, 3, 4 ; Majidi RF4 ; Koopaei MN2 ; Ravari NS1, 2 ; Amini M5 ; Darvishi B1, 4 ; Ostad SN6 ; Atyabi F1, 2 ; Dinarvand R1, 2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Nanotechnology Research Centre, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Pharmaceutics, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Department of Bioengineering, University of California, Riverside, CA, United States
  4. 4. Medical Nanotechnology Department, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran
  5. 5. Department of Medicinal Chemistry, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
  6. 6. Department of Toxicology and Pharmacology, Faculty of Pharmacy, Tehran University of Medical Science, Tehran, Iran

Source: DARU# Journal of Pharmaceutical Sciences Published:2015


Abstract

Background: Nanoparticles (NPs) play an important role in anticancer delivery systems. Surface modified NPs with hydrophilic polymers such as human serum albumin (HSA) have long half-life in the blood circulation system. Methods: The method of modified nanoprecipitation was utilized for encapsulation of paclitaxel (PTX) in poly (lactic-co-glycolic acid) (PLGA). Para-maleimide benzoic hydrazide was conjugated to PLGA for the surface modifications of PLGA NPs, and then HSA was attached on the surface of prepared NPs by maleimide attachment to thiol groups (cysteines) of albumin. The application of HSA provides for the longer blood circulation of stealth NPs due to their escape from reticuloendothelial system (RES). Then the physicochemical properties of NPs like surface morphology, size, zeta potential, and in-vitro drug release were analyzed. Results: The particle size of NPs ranged from 170 to 190 nm and increased about 20-30 nm after HSA conjugation. The zeta potential was about -6 mV and it decreased further after HSA conjugation. The HSA conjugation in prepared NPs was proved by Fourier transform infrared (FT-IR) spectroscopy, faster degradation of HSA in Differential scanning calorimetry (DSC) characterization, and other evidences such as the increasing in size and the decreasing in zeta potential. The PTX released in a biphasic mode for all colloidal suspensions. A sustained release profile for approximately 33 days was detected after a burst effect of the loaded drug. The in vitro cytotoxicity evaluation also indicated that the HSA NPs are more cytotoxic than plain NPs. Conclusions: HSA decoration of PLGA NPs may be a suitable method for longer blood circulation of NPs. © 2015 Esfandyari-Manesh et al.; licensee BioMed Central.
Other Related Docs
9. Ph-Sensitive Stimulus-Responsive Nanocarriers for Targeted Delivery of Therapeutic Agents, Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology (2016)
10. Silk Fibroin Nanoparticle As a Novel Drug Delivery System, Journal of Controlled Release (2015)